Triad Financial Advisors, Inc. Moderna, Inc. Transaction History

Triad Financial Advisors, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 05, 2023	BUY	$135.66 - $197.02 $135 - $197	1 Added 0.06%	1,541 $236,000
Q4 2022 Feb 14, 2023	BUY	$118.38 - $210.04 $182,305 - $323,461	1,540 New	1,540 $276,000
Q2 2022 Aug 11, 2022	BUY	$117.13 - $176.59 $585 - $882	5 Added 0.33%	1,521 $217,000
Q1 2022 May 09, 2022	BUY	$126.46 - $235.05 $2,023 - $3,760	16 Added 1.07%	1,516 $261,000
Q4 2021 May 09, 2022	BUY	$225.82 - $368.51 $338,730 - $552,765	1,500 New	1,500 $381,000

1,113

241M

9.26M

12.1M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $25.7B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of Triad Financial Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Triad Financial Advisors, Inc. with notifications on news.